These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 39125829)

  • 21. Serum neurofilament light chain, markers of systemic inflammation and clinically relevant depressive symptoms in US adults.
    Guo M; Zhu C
    J Affect Disord; 2024 Oct; 363():572-578. PubMed ID: 39074516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.
    Virhammar J; Nääs A; Fällmar D; Cunningham JL; Klang A; Ashton NJ; Jackmann S; Westman G; Frithiof R; Blennow K; Zetterberg H; Kumlien E; Rostami E
    Eur J Neurol; 2021 Oct; 28(10):3324-3331. PubMed ID: 33369818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofilament light chain in spinal fluid and plasma in multiple system atrophy: a prospective, longitudinal biomarker study.
    Singer W; Schmeichel AM; Sletten DM; Gehrking TL; Gehrking JA; Trejo-Lopez J; Suarez MD; Anderson JK; Bass PH; Lesnick TG; Low PA
    Clin Auton Res; 2023 Dec; 33(6):635-645. PubMed ID: 37603107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurofilament light chain in serum of cancer patients with acute neurological complications.
    Gottiparthy A; Lam K; Kundu S; Yang Z; Tremont-Lukats I; Tummala S
    CNS Oncol; 2024 Dec; 13(1):2386233. PubMed ID: 39136375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19.
    Aamodt AH; Høgestøl EA; Popperud TH; Holter JC; Dyrhol-Riise AM; Tonby K; Stiksrud B; Quist-Paulsen E; Berge T; Barratt-Due A; Aukrust P; Heggelund L; Blennow K; Zetterberg H; Harbo HF
    J Neurol; 2021 Oct; 268(10):3574-3583. PubMed ID: 33743046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL.
    Chen CH; Cheng YW; Chen YF; Tang SC; Jeng JS
    J Neuroinflammation; 2020 Apr; 17(1):124. PubMed ID: 32321529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations.
    Bonetto V; Pasetto L; Lisi I; Carbonara M; Zangari R; Ferrari E; Punzi V; Luotti S; Bottino N; Biagianti B; Moglia C; Fuda G; Gualtierotti R; Blasi F; Canetta C; Montano N; Tettamanti M; Camera G; Grimoldi M; Negro G; Rifino N; Calvo A; Brambilla P; Biroli F; Bandera A; Nobili A; Stocchetti N; Sessa M; Zanier ER
    Front Immunol; 2022; 13():1070379. PubMed ID: 36591311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative delirium is associated with increased plasma neurofilament light.
    Casey CP; Lindroth H; Mohanty R; Farahbakhsh Z; Ballweg T; Twadell S; Miller S; Krause B; Prabhakaran V; Blennow K; Zetterberg H; Sanders RD
    Brain; 2020 Jan; 143(1):47-54. PubMed ID: 31802104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum neurofilament light chain in progressive supranuclear palsy.
    Donker Kaat L; Meeter LH; Chiu WZ; Melhem S; Boon AJW; Blennow K; Zetterberg H; van Swieten JC
    Parkinsonism Relat Disord; 2018 Nov; 56():98-101. PubMed ID: 29937097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
    de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
    Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurofilament light chain: A novel blood biomarker in patients with ataxia telangiectasia.
    Veenhuis SJG; Gupta AS; de Gusmão CM; Thornton J; Margus B; Rothblum-Oviatt C; Otto M; Halbgebauer S; van Os NJH; van de Warrenburg BPC; Verbeek MM; Willemsen MAAP
    Eur J Paediatr Neurol; 2021 May; 32():93-97. PubMed ID: 33878608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
    Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Lantero Rodríguez J; Snellman A; Suárez-Calvet M; Blennow K; Zetterberg H; Schöll M;
    JAMA Neurol; 2021 Apr; 78(4):396-406. PubMed ID: 33427873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum neurofilament light protein correlates with unfavorable clinical outcomes in hospitalized patients with COVID-19.
    Prudencio M; Erben Y; Marquez CP; Jansen-West KR; Franco-Mesa C; Heckman MG; White LJ; Dunmore JA; Cook CN; Lilley MT; Song Y; Harlow CF; Oskarsson B; Nicholson KA; Wszolek ZK; Hickson LJ; O'Horo JC; Hoyne JB; Gendron TF; Meschia JF; Petrucelli L
    Sci Transl Med; 2021 Jul; 13(602):. PubMed ID: 34131052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod.
    Piehl F; Kockum I; Khademi M; Blennow K; Lycke J; Zetterberg H; Olsson T
    Mult Scler; 2018 Jul; 24(8):1046-1054. PubMed ID: 28627962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood neurofilament light: a critical review of its application to neurologic disease.
    Barro C; Chitnis T; Weiner HL
    Ann Clin Transl Neurol; 2020 Dec; 7(12):2508-2523. PubMed ID: 33146954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank.
    Wang X; Shi Z; Qiu Y; Sun D; Zhou H
    BMC Med; 2024 May; 22(1):192. PubMed ID: 38735950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma neurofilament light in Huntington's disease: A marker for disease onset, but not symptom progression.
    Parkin GM; Corey-Bloom J; Snell C; Castleton J; Thomas EA
    Parkinsonism Relat Disord; 2021 Jun; 87():32-38. PubMed ID: 33940564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma Neurofilament Light Chain Predicts Cognitive Progression in Prodromal and Clinical Dementia with Lewy Bodies.
    Pilotto A; Imarisio A; Carrarini C; Russo M; Masciocchi S; Gipponi S; Cottini E; Aarsland D; Zetterberg H; Ashton NJ; Hye A; Bonanni L; Padovani A
    J Alzheimers Dis; 2021; 82(3):913-919. PubMed ID: 34151807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.
    Gisslén M; Price RW; Andreasson U; Norgren N; Nilsson S; Hagberg L; Fuchs D; Spudich S; Blennow K; Zetterberg H
    EBioMedicine; 2016 Jan; 3():135-140. PubMed ID: 26870824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.
    Byrne LM; Rodrigues FB; Blennow K; Durr A; Leavitt BR; Roos RAC; Scahill RI; Tabrizi SJ; Zetterberg H; Langbehn D; Wild EJ
    Lancet Neurol; 2017 Aug; 16(8):601-609. PubMed ID: 28601473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.